Skip to main content

Peer Review reports

From: 18-month longitudinal SARS COV-2 neutralizing antibody dynamics in haemodialysis patients receiving heterologous 3-dose vaccination (AZD-1222- AZD-1222- BNT162b2) in a lower middle income setting

Original Submission
6 Dec 2023 Submitted Original manuscript
18 Feb 2024 Reviewed Reviewer Report
28 Mar 2024 Reviewed Reviewer Report
17 Apr 2024 Author responded Author comments - Champa Neelakanthi Ratnatunga
18 Apr 2024 Author responded Author comments - Champa Neelakanthi Ratnatunga
Resubmission - Version 2
17 Apr 2024 Submitted Manuscript version 2
18 Apr 2024 Author responded Author comments - Champa Neelakanthi Ratnatunga
Resubmission - Version 3
18 Apr 2024 Submitted Manuscript version 3
25 Apr 2024 Reviewed Reviewer Report
2 May 2024 Author responded Author comments - Champa Neelakanthi Ratnatunga
2 May 2024 Reviewed Reviewer Report
Resubmission - Version 4
2 May 2024 Submitted Manuscript version 4
Publishing
3 May 2024 Editorially accepted
22 May 2024 Article published 10.1186/s12882-024-03599-7

You can find further information about peer review here.

Back to article page